Hood River Capital Management’s Novavax NVAX Stock Holding History

Hood River Capital Management’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-74,180	Closed	-$13.4M	–	127
2021 Q1	$13.4M	Buy	+74,180	New	+$14.8M	0.43%	82
2016 Q1	–	Sell	-19,347	Closed	-$3.25M	–	96
2015 Q4	$3.25M	Buy	19,347 +1,313	+7%	+$202K	0.42%	78
2015 Q3	$2.55M	Buy	+18,034	New	+$4.04M	0.35%	76

Other funds holding NVAX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Hood River Capital Management's NVAX Position: Q2 2021 in Review

Hood River Capital Management sold out of Novavax (NVAX) in Q2 2021, closing a stake of 74,180 shares — an estimated $13.4M sold.

Hood River Capital Management first reported a position in NVAX in Q3 2015 and held it in 3 quarters. The position peaked at $13.4M in Q1 2021. 407 funds tracked by Wall St. Rank hold NVAX as of Q2 2021.

Hood River Capital Management reported no remaining Novavax position as of Q2 2021 after selling out during the quarter.
Hood River Capital Management sold 74,180 Novavax shares in Q2 2021, an estimated $13.4M.
Hood River Capital Management first reported a position in Novavax in Q3 2015 and held it in 3 quarters.
Hood River Capital Management's Novavax position peaked at $13.4M in Q1 2021.
407 funds tracked by Wall St. Rank held Novavax as of Q2 2021.

Based on Hood River Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.